报价延迟最少15分钟:2026/11/05 11:14 EST
常规时段
|
|
|
|
|
||||||||||||
|
|
|
|
|
238.855 
|
|
|
| 价值评估 |
|
盈利(现时/预测)
10.98/13.24
|
|
企业价值
34.37B
|
| 资产负债 |
|
每股账面净值
42.29
|
| 现金流量 |
|
现金流量率
0.05
|
| 损益表 |
|
收益
5.65B
|
|
每股收益
31.10
|
|
同行比较
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
同行比较之报价最少15分钟延迟 (夜盘时段除外)
|
业务概览
|
|||
| ResMed makes continuous positive airway pressure devices and the masks used to treat obstructive sleep apnea, a condition in which the airway repeatedly collapses during sleep. Devices make up about half of revenue, masks and accessories close to 40%, and residential care software the remainder. Growth depends on diagnosing more of the large untreated sleep apnea population and moving them onto therapy. The Americas contribute about two-thirds of device and mask revenue, with most of the rest from Europe, Japan, and Australia. |
